+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

O4.08 * Agi5198, An Inhibitor Of Idh1R132H, Protects Idh1R132H Hct116 Cells Against Irradiation

O4.08 * Agi5198, An Inhibitor Of Idh1R132H, Protects Idh1R132H Hct116 Cells Against Irradiation

Neuro-Oncology 16(Suppl 2): ii8-ii9

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 067455909

Download citation: RISBibTeXText

DOI: 10.1093/neuonc/nou174.29

Related references

OS2.6Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine. Neuro-Oncology 18(Suppl_4): Iv5-Iv6, 2016

IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis. Plos one 11(5): E0154726, 2016

IDH1R¹³²H decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a. Molecular Medicine Reports 12(5): 6695-6701, 2015

Spontaneous in vitro senescence of glioma cells confirmed by an antibody against IDH1R132H. Anticancer Research 34(6): 2859-2867, 2014

Characterization of the oncogenic properties of mutant isocitrate dehydrogenase 1 (Idh1R132H) in human primary cells. European Journal of Cancer 50: 128-129, 2014

Mutant IDH1R132H Induces Transcriptional and Epigenomic Reprogramming. Cancer Discovery: -, 2017

P09.04Adoptive T cell therapy for Idh1R132H-mutated low-grade glioma. Neuro-Oncology 18(Suppl_4): iv60, 2016

Proximity ligation assay evaluates IDH1R132H presentation in gliomas. Journal of Clinical Investigation 125(2): 593-606, 2015

Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma. Proceedings of the National Academy of Sciences of the United States of America 111(39): 14217-14222, 2014

A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome Research 22(12): 2339-2355, 2012

Os09.9 Identification of Idh1R132H-specific T cell receptors from glioma patients and from Mhc-humanized mice. Neuro-Oncology 19(Suppl_3): iii20, 2017

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation. Biochemical and Biophysical Research Communications 390(3): 547-551, 2009

P03.10 Combined immunohistochemistry for Idh1R132H, p53 and Atrx improves the molecular classification of diffuse gliomas in adults. Neuro-Oncology 19(Suppl_3): iii35, 2017

Immunohistochemical analysis of 1844 human epithelial and haematopoietic tumours and sarcomas for IDH1R132H mutation. Histopathology 58(7): 1167-1172, 2011

Mutant Idh1R132H bears a mutation-specific Cd4 T cell epitope suitable for vaccination of human Cns tumors. Journal of Neuroimmunology 275(1-2): 39, 2014